Portal de Periódicos da CAPES

Bioidentical testosterone cream: A rare cause of postmenopausal virilisation

2009; Wiley; Volume: 49; Issue: 1 Linguagem: Italiano

10.1111/j.1479-828x.2008.00946.x

1479-828X

Cara Megan Ogilvie, Rhona LEVENBERG, Stella R. Milsom,

Reproductive Health and Technologies

Australian and New Zealand Journal of Obstetrics and GynaecologyVolume 49, Issue 1 p. 116-117 Bioidentical testosterone cream: A rare cause of postmenopausal virilisation Cara M. OGILVIE, Cara M. OGILVIE Reproductive Endocrinology, Fertility Associates Ascot HospitalSearch for more papers by this authorRhona LEVENBERG, Rhona LEVENBERG Herne Bay Medical Practice, Auckland, New ZealandSearch for more papers by this authorStella R. MILSOM, Stella R. MILSOM Reproductive Endocrinology, Fertility Associates Ascot HospitalSearch for more papers by this author Cara M. OGILVIE, Cara M. OGILVIE Reproductive Endocrinology, Fertility Associates Ascot HospitalSearch for more papers by this authorRhona LEVENBERG, Rhona LEVENBERG Herne Bay Medical Practice, Auckland, New ZealandSearch for more papers by this authorStella R. MILSOM, Stella R. MILSOM Reproductive Endocrinology, Fertility Associates Ascot HospitalSearch for more papers by this author First published: 03 March 2009 https://doi.org/10.1111/j.1479-828X.2008.00946.xCitations: 1 : Dr Cara M. Ogilvie/Dr Stella Milsom, c/o Fertility Associates, Private Bag 28910, Remuera, Auckland, New Zealand. Email: [email protected] or [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence of alternative medicine. Prev Med 2002; 35: 166–173. 2 El-Hage G, Eden JA, Manga RZ. A double-blind randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder. Climacteric 2007; 10: 335–343. 3 Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood and sexual function in premenopausal women. Menopause 2003; 10: 390–398. 4 Food and Drug Administration, Center for Drug Evaluation and Research. Report: Limited FDA survey of compounded drug products. [Accessed 16 January 2008.] Available from URL: http://www.fda.gov/cder/pharmcomp/survey.htm. 5 Wollina U, Pabst F, Schonlebe J et al . Side effects of topical androgenic and anabolic substances and steroids. A short review. Acta Dermatovenerol Alp Panonica Adriat 2007; 16: 117–122. 6 Svoren BM, Walfsdorf JI. Sexual development in a 21-month-old boy caused by testosterone contamination of a topical hydrocortisone cream. J Pediatr Endocrinol Metabol 2005; 18: 507–510. 7 Eden JA, Hacker NF, Fortune M. Three cases of endometrial cancer associated with bioidentical hormone replacement therapy. Med J Aust 2007; 187: 244–245. Citing Literature Volume49, Issue1February 2009Pages 116-117 ReferencesRelatedInformation